Sign up
Log in
12 Health Care Stocks Moving In Thursday's Intraday Session
Share
Listen to the news

Gainers

  • ModivCare (NASDAQ:MODV) shares rose 72.7% to $3.99 during Thursday's regular session. The company's market cap stands at $57.2 million.
  • Liminatus Pharma (NASDAQ:LIMN) shares rose 57.35% to $20.0. The company's market cap stands at $534.2 million.
  • Eyenovia (NASDAQ:EYEN) shares rose 43.26% to $2.98. The company's market cap stands at $8.5 million.
  • I-MAB (NASDAQ:IMAB) stock rose 39.16% to $2.49. The company's market cap stands at $201.4 million.
  • Kronos Bio (NASDAQ:KRON) shares rose 28.34% to $0.87. The market value of their outstanding shares is at $52.8 million.
  • Phio Pharma (NASDAQ:PHIO) stock increased by 23.8% to $2.6. The company's market cap stands at $12.4 million.

Losers

  • Helius Medical Tech (NASDAQ:HSDT) stock declined by 58.9% to $1.34 during Thursday's regular session.
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares fell 46.9% to $0.77. The market value of their outstanding shares is at $18.2 million.
  • Cibus (NASDAQ:CBUS) stock declined by 33.27% to $1.57. The company's market cap stands at $51.4 million.
  • Lyell Immunopharma (NASDAQ:LYEL) stock declined by 25.32% to $10.06. The company's market cap stands at $148.9 million.
  • Regenxbio (NASDAQ:RGNX) stock declined by 15.93% to $8.47. The company's market cap stands at $425.1 million.
  • Hoth Therapeutics (NASDAQ:HOTH) shares decreased by 15.7% to $1.29. The company's market cap stands at $17.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.